 |
| Ray Jordan |
Ray Jordan, who held top PR jobs at Amgen, Johnson & Johnson and Pfizer, has joined biotech firm Moderna, which has developed the first US COVID-19 vaccine to post positive trial results.
He will take the chief corporate affairs officer slot.
Jordan was previously senior VP, corporate affairs at Amgen, where he was responsible for all internal and external communications, issues management and philanthropy. Prior to joining Amgen, he was VP of public affairs and corporate communication for Johnson & Johnson, and has also served as VP of communications and information at Pfizer.
“His strategic communications and management experience at global commercial biopharmaceutical companies will be a tremendous asset as we continue into late-stage commercial development of our COVID-19 vaccine and our CMV vaccine,” said Moderna chief executive officer Stéphane Bancel.
Moderna has strategic alliances with Merck, AstraZeneca, Pentagon's Defense Advanced Research Projects Agency and Biomedical Advanced Research and Development Authority, which is part of the Dept. of Health and Human Services.
Israel is in advanced discussions with Moderna to buy its vaccine, which will begin a test trial of 30,000 volunteers next month.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
